ZA201207900B - Fast dissolving drug delivery systems - Google Patents

Fast dissolving drug delivery systems

Info

Publication number
ZA201207900B
ZA201207900B ZA2012/07900A ZA201207900A ZA201207900B ZA 201207900 B ZA201207900 B ZA 201207900B ZA 2012/07900 A ZA2012/07900 A ZA 2012/07900A ZA 201207900 A ZA201207900 A ZA 201207900A ZA 201207900 B ZA201207900 B ZA 201207900B
Authority
ZA
South Africa
Prior art keywords
drug delivery
delivery systems
fast dissolving
dissolving drug
fast
Prior art date
Application number
ZA2012/07900A
Inventor
Dominique Costantini
Original Assignee
Applied Pharma Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US12/729,735 external-priority patent/US20110237563A1/en
Priority claimed from EP10305288A external-priority patent/EP2377526A1/en
Application filed by Applied Pharma Res filed Critical Applied Pharma Res
Publication of ZA201207900B publication Critical patent/ZA201207900B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Otolaryngology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Hospice & Palliative Care (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA2012/07900A 2010-03-23 2012-10-19 Fast dissolving drug delivery systems ZA201207900B (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US12/729,735 US20110237563A1 (en) 2010-03-23 2010-03-23 Fast dissolving drug delivery systems
EP10305288A EP2377526A1 (en) 2010-03-23 2010-03-23 Fast dissolving drug delivery systems
PCT/EP2011/054482 WO2011117313A1 (en) 2010-03-23 2011-03-23 Fast dissolving drug delivery systems

Publications (1)

Publication Number Publication Date
ZA201207900B true ZA201207900B (en) 2013-06-26

Family

ID=44070534

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA2012/07900A ZA201207900B (en) 2010-03-23 2012-10-19 Fast dissolving drug delivery systems

Country Status (9)

Country Link
EP (1) EP2549988A1 (en)
KR (1) KR20130012067A (en)
CN (1) CN103025321A (en)
AU (1) AU2011231645A1 (en)
BR (1) BR112012024092A2 (en)
CA (1) CA2794042A1 (en)
RU (1) RU2560693C2 (en)
WO (1) WO2011117313A1 (en)
ZA (1) ZA201207900B (en)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TR201902233T4 (en) 2009-10-30 2019-03-21 Ix Biopharma Ltd Fast dissolving solid dosage form.
CN102920683B (en) * 2012-06-11 2013-08-14 江苏豪森药业股份有限公司 Olanzapine oral instant membrane
CN102860997A (en) * 2012-09-28 2013-01-09 天津市聚星康华医药科技有限公司 Ondansetron oral cavity instant membrane capable of sheltering taste and preparation method thereof
CN102846581A (en) * 2012-09-28 2013-01-02 天津市聚星康华医药科技有限公司 Ambroxol hydrochloride oral fast-dissolving film and preparation method thereof
JP2015533155A (en) * 2012-10-11 2015-11-19 アイエックス バイオファーマ リミテッド Solid dosage form
CN103432105A (en) * 2013-09-02 2013-12-11 天津市聚星康华医药科技有限公司 Meclozine oral film and preparation method thereof
CN104666280B (en) * 2015-03-21 2017-10-13 合肥华方医药科技有限公司 A kind of Glipizide oral cavity dissolving films and preparation method thereof
CN104958279A (en) * 2015-06-27 2015-10-07 万特制药(海南)有限公司 Loratadine oral quickly-soluble film and preparation method thereof
CN104940174A (en) * 2015-07-23 2015-09-30 合肥华方医药科技有限公司 Preparation method of donepezil oral fast dissolving film
DE102017112527B4 (en) * 2017-06-07 2019-01-03 Lts Lohmann Therapie-Systeme Ag Fast disintegrating foam wafers with a high basis weight
AU2017445093B2 (en) 2017-12-29 2024-09-19 Exentis Knowledge Gmbh Drug delivery system
CN108078962A (en) * 2018-01-29 2018-05-29 中国药科大学 A kind of instant film of donepezil hydrochloride orally and preparation method thereof
CN108142940B (en) * 2018-02-05 2021-05-14 中山大学附属第三医院（中山大学肝脏病医院） Soft tablet for promoting swallowing and preparation method thereof
US20210267934A1 (en) * 2018-07-15 2021-09-02 Rapid Dose Therapeutics Corp. Cannabinoid oral dispersible film strip
CN118082156A (en) 2019-01-31 2024-05-28 日精Asb机械株式会社 Device and method for regulating temperature of preform, and device and method for producing resin molded container
KR20210111307A (en) 2019-01-31 2021-09-10 닛세이 에이. 에스. 비 기카이 가부시키가이샤 Resin container manufacturing apparatus, temperature control apparatus, resin container manufacturing method and temperature control method
KR102643807B1 (en) 2019-01-31 2024-03-05 닛세이 에이. 에스. 비 기카이 가부시키가이샤 Manufacturing equipment and manufacturing method for resin containers
EP3919256A4 (en) 2019-01-31 2022-10-12 Nissei Asb Machine Co., Ltd. Device and method for producing resin container
US11179331B1 (en) 2020-04-21 2021-11-23 Cure Pharmaceutcai Holding Corp Oral soluble film containing sildenafil citrate

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1134163A (en) 1993-08-19 1996-10-23 辛勒斯治疗系统公司 Water-soluble pressure-sensitive mucoadhesive and devices provided therewith for emplacement in mucosa-lined body cavity
US5800832A (en) 1996-10-18 1998-09-01 Virotex Corporation Bioerodable film for delivery of pharmaceutical compounds to mucosal surfaces
AU2002365936A1 (en) * 2001-11-16 2003-09-02 Eisai Co. Ltd Compositions and methods to treat gastrointestinal disorders
US6750291B2 (en) 2002-04-12 2004-06-15 Pacific Corporation Film-forming agent for drug delivery and preparation for percutaneous administration containing the same
WO2003093260A1 (en) 2002-04-30 2003-11-13 Biogal Gyogyszergyar Rt. Novel crystal forms of ondansetron, processes for their preparation, pharmaceutical compositions containing the novel forms and methods for treating nausea using them
CN100508976C (en) * 2003-07-24 2009-07-08 史密丝克莱恩比彻姆公司 Orally dissolving films
ES2238001B1 (en) 2004-01-21 2006-11-01 Vita Cientifica, S.L. NEW POLYMORPHIC FORMS OF ONDANSETRON, PROCEDURES FOR THEIR PREPARATION, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USE AS ANANTIMETICS.
DK2351555T3 (en) * 2004-02-23 2017-01-23 Euro Celtique Sa Abuse-safe transdermal opioid delivery device
DE102005033942A1 (en) * 2005-07-20 2007-02-22 Hexal Ag Non-spitting, oral, fast-disintegrating film for antiemetic or antimigraine
FR2905268B1 (en) 2006-09-01 2009-01-23 Unither Dev Soc Par Actions Si SALIVARY SUBSTITUTE
PL2248519T3 (en) * 2006-10-02 2018-04-30 Apr Applied Pharma Research S.A. Non-mucoadhesive film dosage forms
WO2008098195A2 (en) * 2007-02-09 2008-08-14 Todd Maibach Film comprising nitroglycerin
WO2008140460A1 (en) * 2007-05-16 2008-11-20 Fmc Corporation Solid form
US20090004254A1 (en) * 2007-06-19 2009-01-01 Todd Maibach Film comprising active drugs
US20090047330A1 (en) * 2007-08-17 2009-02-19 Ramesh Bangalore Oral fast dissolving films for erectile dysfunction bioactive agents
US20090047350A1 (en) * 2007-08-17 2009-02-19 Ramesh Bangalore Perforated water soluble polymer based edible films
WO2009043588A2 (en) * 2007-10-02 2009-04-09 LABTEC Gesellschaft für technologische Forschung und Entwicklung mbH Ph regulating antibacterial films for the oral or vaginal cavity

Also Published As

Publication number Publication date
KR20130012067A (en) 2013-01-31
EP2549988A1 (en) 2013-01-30
BR112012024092A2 (en) 2016-09-06
CA2794042A1 (en) 2011-09-29
AU2011231645A1 (en) 2012-10-18
RU2560693C2 (en) 2015-08-20
CN103025321A (en) 2013-04-03
AU2011231645A2 (en) 2012-12-20
RU2012144848A (en) 2014-04-27
WO2011117313A1 (en) 2011-09-29

Similar Documents

Publication Publication Date Title
ZA201207900B (en) Fast dissolving drug delivery systems
GB2479953B (en) Drug delivery device
HK1179542A1 (en) Drug delivery device
PL2654864T3 (en) System for drug delivery
GB2491327B (en) Delayed prolonged drug delivery
SG10201700716VA (en) Drug delivery device
EP2665431C0 (en) Drug delivery technology
HRP20181316T1 (en) Drug delivery technology
HRP20181707T1 (en) A drug delivery system
PL2437736T3 (en) Drug delivery systems
IL227352A0 (en) Ocular drug delivery system
ZA201309156B (en) Drug delivery system
ZA201208185B (en) Intravaginall drug delivery device
EP2547384A4 (en) Gas-pressured medication delivery device
EP2626055A4 (en) Drug delivery device
GB201018750D0 (en) Drug delivery system
AU2010904901A0 (en) Drug delivery device